Copper-Catalyzed Oxidation Mediates PAF Formation in Human LDL Subspecies
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (12) , 3505-3512
- https://doi.org/10.1161/01.atv.17.12.3505
Abstract
Free radical-mediated oxidation of cholesterol-rich LDL plays a key role in atherogenesis and involves the formation of oxidized phospholipids with proinflammatory biological activity. We evaluated the production of platelet-activating factor (PAF), a potent inflammatory mediator, in human LDL subspecies on copper-initiated oxidation (4 μmol/L CuCl2, 80 μg/mL for 3 hours at 37°C). PAF formation was determined by biological assay of HPLC-purified lipid extracts of copper-oxidized lipoproteins; chemical identity was confirmed by gas chromatographic and mass spectrometric analyses. PAF, characterized as the C16:0 molecular species, was preferentially produced in intermediate LDL (d=1.029 to 1.039 g/mL) (8.6±5.7 pmol PAF/3 h per mg LDL protein) and light LDL (d=1.019 to 1.029 g/mL), but was absent from dense LDL particles (d=1.050 to 1.063 g/mL). As PAF:acetylhydrolase inactivates PAF and oxidized forms of phosphatidylcholine, we evaluated the relationship of lipoprotein-associated PAF:acetylhydrolase to PAF formation. We confirmed that PAF:acetylhydrolase activity was elevated in native, dense LDL (41.5±9.5 nmol/min per mg protein) but low in LDL subspecies of light and intermediate density (d 1.020 to 1.039 g/mL) (3.5±1.6 nmol/min per mg protein) [Tselepis et al,Arterioscler Thromb Vasc Biol.1995;15:1764–1773]. On copper-mediated oxidation for 3 hours at 37°C, dense LDL particles conserved 20±14% of their initial enzymatic activity; in contrast, PAF:acetylhydrolase activity was abolished in light and intermediate LDL subspecies. Clearly, the elevated PAF: acetylhydrolase activity of dense LDL efficiently diminishes the potential inflammatory role of endogenously formed PAF; nonetheless, formation of proatherogenic lysophospholipids results. In contrast, LDL particles of the light and intermediate subclasses can accumulate PAF on oxidative modification.Keywords
This publication has 60 references indexed in Scilit:
- Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.Journal of Clinical Investigation, 1995
- Plasmalogen Phospholipids as Potential Protectors Against Lipid Peroxidation of Low-Density LipoproteinsBiochemical and Biophysical Research Communications, 1994
- Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivatedBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Biosynthesis of paf-acether XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolaseBiochemical and Biophysical Research Communications, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophagesBiochemical and Biophysical Research Communications, 1988
- Studies on ether phospholipidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984